Literature DB >> 11375130

Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice.

L Friis-Hansen1, K A Lacourse, L C Samuelson, J J Holst.   

Abstract

The maturation of many peptide hormones is attenuated in carboxypeptidase E (CPE)-deficient fat/fat mice, leading to a slowly developing, adult-onset obesity with mild diabetes. To determine the contribution of the hormones generated from the proglucagon precursor to this phenotype, we studied the tissue-specific processing of glucagon and glucagon-like peptide-1 (GLP-1) in these mice. In all tissues examined there was a great reduction in mature amidated GLP-1. Furthermore, a lack of CPE attenuates prohormone convertase processing of proglucagon in both the pancreas and the intestine. These findings suggest that defects in proglucagon processing together with other endocrine malfunctions could contribute to the diabetic and obesity phenotype in fat/fat mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375130     DOI: 10.1677/joe.0.1690595

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata.

Authors:  Clive Wasserfall; Harry S Nick; Martha Campbell-Thompson; Dawn Beachy; Leena Haataja; Irina Kusmartseva; Amanda Posgai; Maria Beery; Christopher Rhodes; Ezio Bonifacio; Peter Arvan; Mark Atkinson
Journal:  Cell Metab       Date:  2017-09-05       Impact factor: 27.287

2.  Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.

Authors:  R W Gelling; X Q Du; D S Dichmann; J Romer; H Huang; L Cui; S Obici; B Tang; J J Holst; C Fledelius; P B Johansen; L Rossetti; L A Jelicks; P Serup; E Nishimura; M J Charron
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-24       Impact factor: 11.205

3.  The EGL-21 carboxypeptidase E facilitates acetylcholine release at Caenorhabditis elegans neuromuscular junctions.

Authors:  Tija C Jacob; Joshua M Kaplan
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

Review 4.  Glucagon-like peptide-1 gene therapy.

Authors:  Anne M Rowzee; Niamh X Cawley; John A Chiorini; Giovanni Di Pasquale
Journal:  Exp Diabetes Res       Date:  2011-06-20

5.  Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and Hypogonadotrophic Hypogonadism.

Authors:  Suzanne I M Alsters; Anthony P Goldstone; Jessica L Buxton; Anna Zekavati; Alona Sosinsky; Andrianos M Yiorkas; Susan Holder; Robert E Klaber; Nicola Bridges; Mieke M van Haelst; Carel W le Roux; Andrew J Walley; Robin G Walters; Michael Mueller; Alexandra I F Blakemore
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

6.  Predicting proteolytic sites in extracellular proteins: only halfway there.

Authors:  Yossef Kliger; Eyal Gofer; Assaf Wool; Amir Toporik; Avihay Apatoff; Moshe Olshansky
Journal:  Bioinformatics       Date:  2008-03-04       Impact factor: 6.937

Review 7.  Actions of glucagon-like peptide-1 receptor ligands in the gut.

Authors:  Jens Juul Holst; Daniel Bjørklund Andersen; Kaare Villum Grunddal
Journal:  Br J Pharmacol       Date:  2021-08-04       Impact factor: 8.739

8.  The regulated secretory pathway and human disease: insights from gene variants and single nucleotide polymorphisms.

Authors:  Wei-Jye Lin; Stephen R Salton
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-06       Impact factor: 5.555

9.  Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production.

Authors:  Nicolai J Wewer Albrechtsen; Rune E Kuhre; Daniel Hornburg; Christian Z Jensen; Mads Hornum; Carsten Dirksen; Maria Svane; Lærke S Gasbjerg; Nils B Jørgensen; Maria N Gabe; Emilie Balk-Møller; Reidar Albrechtsen; Marie Winther-Sørensen; Katrine D Galsgaard; Felix Meissner; Tina Jorsal; Asger Lund; Tina Vilsbøll; Rasmus Eliasen; Kirstine N Bojsen-Møller; Thomas Idorn; Carolyn F Deacon; Filip K Knop; Mette M Rosenkilde; Bolette Hartmann; Bo Feldt-Rasmussen; Matthias Mann; Sten Madsbad; Jens J Holst
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.